Recombinant viral vectors
US10844095B2 · kind B2 · utility
0Cited by
1References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 4, 2019 |
| Grant date | Nov 24, 2020 |
| Priority date | — |
| Expiry date | Feb 4, 2039 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/162
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present relation relates to recombinant vesicular stomatitis virus for use as prophylactic and therapeutic vaccines for infectious diseases of AIDS. The present invention encompasses the preparation and purification of immunogenic compositions which are formulated into the vaccines of the present invention.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.